Invasive cervical cancer (ICC) is the most common cause of cancer death worldwide, and while decreasing in prevalence in the majority of the developed world, this disease continues to disproportionately affect certain populations in the United States (US). In particular, the rate of ICC incidence and mortality in Appalachian women is the highest in the US. While many risk factors are known to influence ICC development, little is known about the role of hereditary and genetic susceptibility factors. The transforming growth factor beta (TGF-B) is a universal critical regulator of various cellular functions, including cell proliferation, via its binding with a receptors complex on the cell surface. Cancer cells frequently avoid the inhibitory influence of TGF-B on cell proliferation via somatic inactivation of key components of the signaling pathway, including the ligand and receptor complex. Additionally, germline polymorphisms in the ligand and receptors have been associated with cancer development and increased cancer susceptibility. In this proposal, we hypothesize that the increased incidence of ICC observed in Appalachian women over their non-Appalachian counterparts is due in part to inherited and somatic alteration of the TGF-B ligand and receptor complex that can be further potentiated in association with various environmental, behavioral, and socioeconomic risk factors. Specifically, we will determine prevalence of inherited polymorphic and somatically acquired variants of key TGF-B pathway components in a large cohort of Appalachian ICC patients compared to healthy Appalachian women. Furthermore, we will determine whether these genetic alterations contribute individually or in combination with other known environmental (Human Papillomavirus, Epstein-Barr Virus), behavioral (smoking), and social (stress, social networks) risk factors, to the increased susceptibility of Appalachian women to ICC development.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-3)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
United States
Zip Code
Smith, Caren E; Fullerton, Stephanie M; Dookeran, Keith A et al. (2016) Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities. Health Aff (Millwood) 35:1367-73
Paskett, Electra D; Krok-Schoen, Jessica L; Pennell, Michael L et al. (2016) Results of a Multilevel Intervention Trial to Increase Human Papillomavirus (HPV) Vaccine Uptake among Adolescent Girls. Cancer Epidemiol Biomarkers Prev 25:593-602
Thomson, Tiffany L; Krebs, Valdis; Nemeth, Julianna M et al. (2016) Social Networks and Smoking in Rural Women: Intervention Implications. Am J Health Behav 40:405-15
Hohl, Sarah D; Thompson, Beti; Krok-Schoen, Jessica L et al. (2016) Characterizing Community Health Workers on Research Teams: Results From the Centers for Population Health and Health Disparities. Am J Public Health 106:664-70
Krok-Schoen, Jessica L; Oliveri, Jill M; Young, Gregory S et al. (2016) Evaluating the stage of change model to a cervical cancer screening intervention among Ohio Appalachian women. Women Health 56:468-86
Golden, Sherita Hill; Ferketich, Amy; Boyington, Josephine et al. (2015) Transdisciplinary cardiovascular and cancer health disparities training: experiences of the centers for population health and health disparities. Am J Public Health 105 Suppl 3:S395-402
Kelly, Kimberly M; Schoenberg, Nancy; Wilson, Tomorrow D et al. (2015) Cervical cancer worry and screening among appalachian women. J Prim Prev 36:79-92
Llanos, Adana A; Pennell, Michael L; Young, Gregory S et al. (2015) No association between colorectal cancer worry and screening uptake in Appalachian Ohio. J Public Health (Oxf) 37:322-7
Plascak, Jesse J; Fisher, James L; Paskett, Electra D (2015) Primary care physician supply, insurance type, and late-stage cancer diagnosis. Am J Prev Med 48:174-8
Katz, Mira L; Paskett, Electra D (2015) The process of engaging members from two underserved populations in the development of interventions to promote the uptake of the HPV vaccine. Health Promot Pract 16:443-53

Showing the most recent 10 out of 69 publications